Review of nintedanib plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma: phase II results from the randomized, placebo-controlled LUME-Meso trial.

ABSTRACT:

SUBMITTER: Lee P 

PROVIDER: S-EPMC6186601 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature